Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of pregabalin in partial seizures
NCT00150293Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of pregabalin in focal seizures, sponsored by Pfizer. Started Mar 2002; status: completed.
02
Drugs
pregabalin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00150293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150293.